{"id":2303,"date":"2020-11-09T00:00:00","date_gmt":"2020-11-09T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2303"},"modified":"2020-11-09T00:00:00","modified_gmt":"2020-11-09T00:00:00","slug":"centogene-baut-%e7%b5%84%e5%90%88%e6%98%af%e4%b8%80%e7%a8%ae%e5%89%b5%e6%96%b0%e7%9a%84-sars-cov-2-%e6%b8%ac%e8%a9%a6%ef%bc%8c%e7%94%a8%e6%96%bc-fujirebio-%e7%9a%84-angebot-schneller-%e5%92%8c-hochqua","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/tw\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\/","title":{"rendered":"CENTOGENE baut \u5275\u65b0 SARS-CoV-2-Testl\u00f6sungen \u7522\u54c1\u7d44\u5408\uff1aAngebot schneller \u548c Hochqualitativer COVID-19-Antigen-Tests auf Basis der Technologie von Fujirebio"},"content":{"rendered":"<p>\u7f8e\u570b\u9ebb\u85a9\u8af8\u585e\u5dde\u528d\u6a4b\u4ee5\u53ca\u5fb7\u570b\u7f85\u65af\u6258\u514b\u548c\u67cf\u6797\uff0c2020 \u5e74 11 \u6708 9 \u65e5<\/p>\n<ul>\n<li>\u65b0\u51a0\u80ba\u708e (COVID-19) \u6aa2\u6e2c\u975e\u5e38\u9748\u6d3b\u3002 Die Zeitspanne bis zum Vorliegen eines Testergebnisses ist f\u00fcr viele Alltagssituationen dabei ein entscheidendes Kriterium.<\/li>\n<li>\u9a57\u8b49\u3001\u9ad8\u654f\u611f\u6297\u539f\u6e2c\u8a66 erm\u00f6glicht einen \u00fcbermittelten Laborbefund nach 75 Minuten\uff08\u5728\u6f22\u5821\uff09bis 2,5 Stunden\uff08\u5728\u6cd5\u862d\u514b\u798f\uff09\u548c erweitert gut etabliertes Angebot \u548c Covid-19-PCR-\u6e2c\u8a66\uff0cdie bereits an vier utsir\u3002.<\/li>\n<li>\u6f22\u838e\u822a\u7a7a\u6297\u539f\u6e2c\u8a66\u4e2d\u5fc3\u4f4d\u65bc\u6f22\u5821\u548c\u7f8e\u56e0\u6cb3\u7554\u6cd5\u862d\u514b\u798f\u7684 CENTOGENE-Flughafen-Testzentren\u3002.<\/li>\n<\/ul>\n<p>Centogene NV\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aCNTG\uff09\uff0cein wirtschaftliches Unternehmen\uff0cdas auf die Diagnostik seltener erkrankungen spezialisiert ist und klinische sowie Genetische Daten von einsetzt\uff0c\u7acb\u5373\u958b\u59cb\uff0c\u6211\u5011\u5c07\u8207 LUMIPULSE\u00ae G \u7684Fujirebio \u5408\u4f5c\u5925\u4f34\u4e00\u8d77\u8a0e\u8ad6 IVD \u6e2c\u8a66\u5c08\u696d\u4eba\u58eb\u7684\u4e16\u754c\u6280\u8853\u3002.<\/p>\n<p>erkl\u00e4rte \u7684 CENTOGENE \u9996\u5e2d\u8cc7\u8a0a\u9577 Volkmar Weckesser \u535a\u58eb\uff1a\u300cIn den letzten Monaten haben wir einen steigenden Bedarf an leicht zug\u00e4nglichen, verl\u00e4sslichen und schnellen Tests auf das Coronr. haben Monate Testzentren \u662f\u5fb7\u570b\u98db\u884c\u6e2c\u8a66\u4e2d\u5fc3\u7684\u6838\u5fc3\u670d\u52d9\uff0c\u7531 Mithilfe von Fujirebios fortgeschrittener Technologie zu erweitern\u3001dass die Zeitspanne bis zum Vorliegen eines Testergebnis f\u00fcr viele \u63d0\u4f9b\u3002 des Tests nicht wesentlich abnehmen)\u3002 machen.\u201e<\/p>\n<p>CENTOGENE \u8207 Schnell \u6e2c\u8a66\u7684\u5275\u65b0\u6e2c\u8a66\u7d44\u5408\u7684\u6700\u4f73\u5408\u4f5c\uff0c\u5c07\u5728 Labour \u4e2d\u9032\u884c\u63a2\u7d22\u3002.<\/p>\n<p>CENTOGENE \u9996\u5e2d\u57fa\u56e0\u7d44\u9577 Peter Bauer \u535a\u58eb\u6559\u6388\u6559\u6388\uff0cf\u00fcgte hinzu\uff1a\u300cCENTOGENE hat diese Antigen-Testl\u00f6sung in den vergangenen Wochen umfangreich validiert. In Kombination mit unserer digitalen Labor- vongreich congey. In Kombination mit unserer digitalen Labor- von Bwe Fujirebio basierenden 93% \u6297\u539f\u6aa2\u6e2c\u967d\u6027\u3002 CENTOGENE \u662f\u8207\u6f22\u838e\u822a\u7a7a\u7684\u7368\u5bb6\u5408\u4f5c\u5925\u4f34\u3002.<\/p>\n<p>\u201e\u300cMit unserer Teststrategie verfolgen wir das Ziel, durch die gewonnenen Daten wichtige Erkenntnisse im Umgang mit Antigentests zu sammeln. Wir sind davon \u00fcberzeugt, dass es der einzign strid Yegegierzigional li counier, falional sturzig\u8ab2weiter\u6f22\u838e\u822a\u7a7a\u8207 CENTOGENE \u7684\u5408\u4f5c\uff0c\u5fb7\u570b\u6f22\u838e\u822a\u7a7a\u96c6\u5718\u840a\u7279\u7279\u5de5\u4f5c\u7d44\u6e2c\u8a66\u90e8\u9580\u7684\u8ca0\u8cac\u4eba Ma\u00dfstab f\u00fcr ein erfolgreiches Testmodell\u300d\u3002.<\/p>\n<p>11 \u6708\u7684\u6297\u539f\u6e2c\u8a66\u662f\u6700\u597d\u7684 PCR \u57fa\u790e\u6e2c\u8a66\uff0c\u5728\u6f22\u5821\u548c\u6cd5\u862d\u514b\u798f\u7684 CENTOGENE-Testzentren \u4e2d\u9032\u884c\u4e86\u6e2c\u8a66\u3002.<\/p>\n<p>\u6211\u5011\u5c07\u8a73\u7d30\u4ecb\u7d39 CENTOGENE \u7684 SARS-CoV-2-\u6297\u539f\u6e2c\u8a66 \u2013 \u6280\u8853\u3001\u6280\u8853\u3001\u7cbe\u6e96\u548c\u9a57\u8b49 \u2013 \u8207 Fujirebio \u5408\u4f5c\uff0c\u65bc 2020 \u5e74 11 \u6708 9 \u65e5\u4e0a\u5348 12:30 \u8207 Fujirebio \u9032\u884c\u5408\u4f5c\u3002\u6bd4\u7279\u6885\u723e\u767b Sie sich <a href=\"mailto:centogene@mc-services.eu\" title=\"\u50b3\u9001\u96fb\u5b50\u90f5\u4ef6\">\u9019\u88e1<\/a>&nbsp;\u4e00\u500b\u3002\u8acb\u505c\u6b62\u4e26\u7d50\u675f\u8207 Microsoft Teams \u6703\u8b70\u7684\u9023\u7d50\u7684\u7d42\u6b62\u3002.<\/p>\n<h2 class=\"h3\">\u9ad8\u654f\u611f\u5ea6\u6297\u539f\u6e2c\u8a66 PCR-basierte \u6e2c\u8a66<\/h2>\n<p>\u6211\u7684 Rahmen der Partnerschaft \u8207 Fujirebio \u548c Lumipulse G SARS-CoV-2 Ag Proben \u7a69\u5b9a\u6aa2\u6e2c\uff0c\u900f\u904e\u81ea\u52d5\u5316\u5b78\u767c\u5149\u548c\u5316\u5b78\u767c\u5149\u5e73\u53f0 LUMIPULSE G1200 Ger\u00e4ten durchgef\u00fchrt werden\uff0cgew\u00e4hrleisten\u3002\u5728 CENTOGENE \u4e2d\u9032\u884c\u62bd\u8c61\u6e2c\u8a66\uff0c\u4e26\u5728 CENTOGENE \u7279\u5fb5\u6e2c\u8a66\u5be6\u9a57\u5ba4\u5206\u6790\u4e2d\u9032\u884c\u6e2c\u8a66\u3002 LUMIPULSE G1200 \u5df2\u5b8c\u6210\u6e2c\u8a66\uff0c\u5728 40 \u5206\u9418\u5167\u9032\u884c\u9ad8\u54c1\u8cea\u6e2c\u8a66\u3002 CENTOGENE \u7684\u7db2\u8def\u8a2d\u5b9a\u548c\u81ea\u52d5\u5316\u914d\u7f6e\u3001\u8a2d\u5099\u548c\u76f4\u63a5\u63a7\u5236\u5c07\u5728\u667a\u6167\u578b\u624b\u6a5f\u6216\u6578\u4f4d\u8a2d\u5099\u4e0a\u9032\u884c\u3002.<\/p>\n<p>Lumipulse G SARS-CoV-2 Ag \u6700\u521d\u662f\u9ad8\u9748\u654f\u6297\u539f\u6e2c\u5b9a\uff0c\u662f\u5316\u5b78\u767c\u5149\u81ea\u52d5\u5316\u5e73\u53f0\u3002\u4eca\u5e74 8 \u6708\uff0c\u65e5\u672c\u6aa2\u75ab\u90e8\u9580\u5c07\u5728 8 \u6708\u9032\u884c\u6aa2\u75ab\u7be9\u6aa2\uff0c\u4e26\u91cd\u65b0\u767c\u5e03\u65e5\u672c\u6d41\u611f\u5927\u7db1\u3002.<\/p>\n<h5>\u512a\u535a CENTOGENE<strong> <\/strong><\/h5>\n<p>CENTOGENE \u7684\u5de5\u4f5c\u5305\u62ec\u81e8\u5e8a\u8a3a\u65b7\u548c\u7814\u7a76\u3001\u81e8\u5e8a\u548c\u907a\u50b3\u5b78\u6578\u64da\u3001\u60a3\u8005\u8cc7\u8a0a\u3001\u85e5\u7269\u548c\u85e5\u7269\uff0c\u4ee5\u53ca\u5be6\u52d9\u7d93\u9a57\u3002 Unser Ziel ist es, die Rationalit\u00e4t von Behandlungsentscheidungen zu unterst\u00fctzen und mit unseren umfassenden Daten, darunter Epidemiologische and klinische Informationen sowie Innovative Biomarker, \u5f88\u5feb\u662f\u4e00\u500b\u5c08\u6709\u7684\u5168\u7403\u5e73\u53f0\u3002 Zum Stand 31. 2020 \u5e74 8 \u6708 umfasste diese etwa 3,6 Milliarden Datenpunkte von rund 570.000 Patienten aus \u00fcber 120 L\u00e4ndern\u3002.<\/p>\n<p>\u8a72\u5e73\u53f0\u662f\u6d41\u884c\u75c5\u5b78\u3001\u8868\u578b\u548c\u907a\u50b3\u5b78\u6578\u64da\u7684\u5feb\u901f\u6d41\u884c\u75c5\u5b78\u3001\u8868\u578b\u548c\u907a\u50b3\u5b78\u6578\u64da\uff0c\u662f\u60a3\u8005\u4e16\u754c\u5404\u5730\u7684\u751f\u7269\u5eab\u548c\u751f\u7269\u63a2\u91dd\u7684\u53c3\u8003\u8cc7\u6599\uff0c\u4e5f\u662f\u7814\u7a76\u7684\u53c3\u8003\u3002 Nach unserem Wissensstand stellt CENTOGENE \u4e16\u754c\u5404\u5730\u7684\u6578\u64da\u9280\u884c bereit\uff0c\u8a72\u6578\u64da\u4e26\u884c auf mehreren Ebenen analysieren kann\u3002\u9019\u662f\u4e00\u500b\u672a\u5b8c\u6210\u7684\u8cc7\u6e90\uff0c\u65e8\u5728\u5e6b\u52a9\u60a8\u4e86\u89e3\u5b64\u5152-\u963f\u723e\u8328\u6d77\u59c6\u7684\u88fd\u85e5\u5de5\u696d\u3002 Zum Stand 31. 2020 \u5e74 8 \u6708\uff0c\u6211\u5011\u5c07\u5728 45 \u865f\u548c 40 \u865f Pharmapartnern zusammengearbeitet \u4e4b\u9593\u9032\u884c\u9078\u64c7\u3002.<\/p>\n<h5><strong>\u5a01\u864e\u864e\u7684\u884c\u70ba\u8207\u884c\u70ba <\/strong><\/h5>\n<p>Diese Pressemitteilung enth\u00e4lt Aussagen\uff0cdie \u201czukunftsgerichtete Aussagen\u201d\uff08\u524d\u77bb\u6027\u8072\u660e\uff09\u662f\u6839\u64da 1995 \u5e74\u7f8e\u570b\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u88fd\u5b9a\u7684\u3002\u934d\u91d1\u7684\u5967\u65af\u85a9\u6839\u3001\u9081\u6069\u6839\u3001\u5384\u74e6\u901a\u6839\u3001\u8d85\u751f\u3001\u5e73\u9762\u3001\u9f4a\u52d2\u3001\u5b89\u7d0d\u9580\u6216\u9810\u6e2c\u672a\u4f86\u7684\u672a\u4f86Fakten Widespiegeln\u3002 Beispiele hierf\u00fcr sind die Discussion unserer Strategien, Finanzierungspl\u00e4ne, Wachstumschancen und des Marktwachstums\u3002\u5728 einigen F\u00e4llen k\u00f6nnen Sie solche zukunftsgerichteten Aussagen anhand von Begriffen wie \u201cerwarten\u201d\u3001\u201cglauben\u201d\u3001\u201csch\u00e4tzen\u201d\u3001\u201cplanen\u201d\u3001\u201canstreben\u201d\u3001\u201cproostizieren\u201d \u6216 \u201cJerwartel\u201d\u3001\u201ck\u00f6nnte\u201d\u3001\u201cJt.S.\u201d Ausdr\u00fccke identifizieren \u7684\u8aaa\u660e\u3002\u672a\u4f86\u6cd5\u9662\u5c07\u6839\u64da\u8cc7\u8a0a\u7ba1\u7406\u689d\u4f8b\u548c\u7ba1\u7406\u689d\u4f8b\uff0c\u5c0d\u8cc7\u8a0a\u9032\u884c\u7ba1\u7406\u3002 Diese zukunftsgerichteten Aussagen sind jedoch keine Garantie f\u00fcr unsere Leistung, und Sie sollten ihnen nicht unangemessen Bedeutung beimessen.\u672a\u4f86\u7684\u5927\u6cd5\u9662\u5c07\u5728\u672a\u4f86\u7684\u65e5\u5b50\u88e1\uff0c\u70ba\u4e16\u754c\u5404\u5730\u7684\u80ba\u708e\u548c\u4e0d\u7a69\u5b9a\u56e0\u7d20\u63d0\u4f9b\u7a69\u5b9a\u56e0\u5b50\u75ab\u60c5\u7684\u8513\u5ef6\u3002 Gesch\u00e4ft und die Gesch\u00e4ftsergebnisse\u3001m\u00f6gliche \u00e4nderungen von aktuellen und vorgeschlagenen Gesetzen\u3001Vorschriften und Regulierungen\u3001der Druck des zunehmenden Wettbewerbs und Konsolidierung in derehid Branch des zune bdieden Wettbewerbs und Konsolidierung in rdehidierung \u5340 bdie Zulassung\uff0c\u6b7b\u4ea1\u4e2d\u7684\u4e0d\u5e78\u7f8e\u570b\u98df\u54c1\u548c\u85e5\u7269\u7ba1\u7406\u5c40\uff0c\u5728 Dritte \u548c\u5408\u4f5c\u5925\u4f34\u4e2d\u7684 Vertrauen\uff0ceinschlie\u00dflich unsere F\u00e4higkeit\uff0cWachstum zu steuern \u548c neue Kundenbeziehungen einzugehen\uff0cunsere Abh\u00e4ngigkeit von neue Kundenbeziehungen einzugehen\uff0cunsere Abh\u00e4ngigkeit von neue Kundenbeziehungen einzugehen\uff0cunsere Abh\u00e4ngigkeit von sder \u201c\u7f55\u898b\u75c5\u201d\u884c\u696d\uff0cunders\uff0c\u570b\u969b\u64f4\u5c55\u3002 zu\u8acb\u6ce8\u610f\uff0c\u500b\u4eba\u7684\u884c\u70ba\u548c\u500b\u4eba\u884c\u70ba\u7684\u672c\u8cea\u7279\u5fb5\u662f\u5728\u4e0d\u78ba\u5b9a\u7684\u60c5\u6cc1\u4e0b\u767c\u751f\u8b8a\u5316\u7684\u3002\u8acb\u6ce8\u610f\uff0c\u8acb\u6ce8\u610f\u4ee5\u4e0b\u4e8b\u9805\uff0c\u8acb\u6ce8\u610f\uff0c\u8acb\u6ce8\u610f\u4ee5\u4e0b\u4e8b\u9805\uff0c\u8acb\u6ce8\u610f\uff0c\u8acb\u6ce8\u610f\u4ee5\u4e0b\u4e8b\u9805\uff1a Viele dieser risiken liegen au\u00dferhalb der Kontrolle des Unternehmens und k\u00f6nnen dazu f\u00fchren, dass die tats\u00e4chlichen Ergebnisse erhebn vonse erhebt vonden \u8ab2zukunftsgerichteten Aussagen gelten nur zum Datum dieser Pressemitteilung \u4e2d\u3002 Das Unternehmen \u00fcbernimt keine Verpflichtung und lehnt ausdr\u00fccklich ab, solche Aussagen zu aktualisieren oder die Ergebnisse von \u00e4nderungen solcher Aussagen \u00f6ffentlich bekannt zu \u826f\u7aef, Ium zign Entwicklungen\u66f4\u5ee3\u6cdb\u7684\u60c5\u6cc1\u662f\uff0c\u73fe\u5728\u7684\u60c5\u6cc1\u662f\u4e0d\u5b58\u5728\u7684\u3002.<\/p>\n<p>Weitere Informationen in unserer Registrierungserkl\u00e4rung f\u00fcr das Jahr, das am 31. Dezember 2019 endete, in unserem 6-K-Statement betreffend die Ergebnisse f\u00fcr das Quartal endend am 31. M\u00e4o\u00e4r. 2020 \u5e74 6 \u6708\uff0c\u8acb\u53c3\u95b1\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703 (SEC) \u7684\u76f8\u95dc\u6587\u4ef6\u548c\u6587\u4ef6\u3002 Sie k\u00f6nnen diese Dokumente erhalten, indem Sie die EDGAR-Funktion <a href=\"http:\/\/www.sec.gov\" target=\"_blank\" title=\"Zur SEC \u7db2\u7ad9\">\u5728\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\u7db2\u7ad9\u4e0a<\/a> \u62dc\u8a2a\u3002.<\/p>\n<h5>\u65b0\u805e\u754c\u7684\u5408\u4f5c\u5925\u4f34\uff1a<strong> <\/strong><\/h5>\n<p>\u4e2d\u5fc3\u57fa\u56e0<br \/> \u672c\u00b7\u840a\u683c<br \/> \u4f01\u696d\u50b3\u64ad\u90e8<br \/> <a href=\"mailto:press@centogene.com\" title=\"\u50b3\u9001\u96fb\u5b50\u90f5\u4ef6\">press@centogene.com<\/a><\/p>\n<p> &nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., USA und ROSTOCK &amp; BERLIN, Deutschland, 09. November 2020 Die Nachfrage nach flexiblen L\u00f6sungen f\u00fcr zuverl\u00e4ssige COVID-19-Tests nimmt [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2303","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CENTOGENE baut Portfolio an innovativen SARS-CoV-2-Testl\u00f6sungen aus: Angebot schneller und hochqualitativer COVID-19-Antigen-Tests auf Basis der Technologie von Fujirebio | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/tw\/centogene-baut-\u7d44\u5408\u662f\u4e00\u7a2e\u5275\u65b0\u7684-sars-cov-2-\u6e2c\u8a66\uff0c\u7528\u65bc-fujirebio-\u7684-angebot-schneller-\u548c-hochqua\/\" \/>\n<meta property=\"og:locale\" content=\"zh_TW\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE baut Portfolio an innovativen SARS-CoV-2-Testl\u00f6sungen aus: Angebot schneller und hochqualitativer COVID-19-Antigen-Tests auf Basis der Technologie von Fujirebio | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., USA und ROSTOCK &amp; BERLIN, Deutschland, 09. November 2020 Die Nachfrage nach flexiblen L\u00f6sungen f\u00fcr zuverl\u00e4ssige COVID-19-Tests nimmt [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/tw\/centogene-baut-\u7d44\u5408\u662f\u4e00\u7a2e\u5275\u65b0\u7684-sars-cov-2-\u6e2c\u8a66\uff0c\u7528\u65bc-fujirebio-\u7684-angebot-schneller-\u548c-hochqua\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-09T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005:\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9810\u4f30\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE baut Portfolio an innovativen SARS-CoV-2-Testl\u00f6sungen aus: Angebot schneller und hochqualitativer COVID-19-Antigen-Tests auf Basis der Technologie von Fujirebio\",\"datePublished\":\"2020-11-09T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\\\/\"},\"wordCount\":1406,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\\\/\",\"name\":\"CENTOGENE baut Portfolio an innovativen SARS-CoV-2-Testl\u00f6sungen aus: Angebot schneller und hochqualitativer COVID-19-Antigen-Tests auf Basis der Technologie von Fujirebio | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2020-11-09T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\\\/#breadcrumb\"},\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE baut Portfolio an innovativen SARS-CoV-2-Testl\u00f6sungen aus: Angebot schneller und hochqualitativer COVID-19-Antigen-Tests auf Basis der Technologie von Fujirebio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-TW\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/tw\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE baut \u5275\u65b0 SARS-CoV-2-Testl\u00f6sungen \u7522\u54c1\u7d44\u5408\uff1aAngebot schneller \u548c Hochqualitativer COVID-19-Antigen-Tests auf Basis der Technologie von Fujirebio |\u4e16\u7d00\u57fa\u56e0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/tw\/centogene-baut-\u7d44\u5408\u662f\u4e00\u7a2e\u5275\u65b0\u7684-sars-cov-2-\u6e2c\u8a66\uff0c\u7528\u65bc-fujirebio-\u7684-angebot-schneller-\u548c-hochqua\/","og_locale":"zh_TW","og_type":"article","og_title":"CENTOGENE baut Portfolio an innovativen SARS-CoV-2-Testl\u00f6sungen aus: Angebot schneller und hochqualitativer COVID-19-Antigen-Tests auf Basis der Technologie von Fujirebio | CENTOGENE","og_description":"CAMBRIDGE, Mass., USA und ROSTOCK &amp; BERLIN, Deutschland, 09. November 2020 Die Nachfrage nach flexiblen L\u00f6sungen f\u00fcr zuverl\u00e4ssige COVID-19-Tests nimmt [&hellip;]","og_url":"https:\/\/www.centogene.com\/tw\/centogene-baut-\u7d44\u5408\u662f\u4e00\u7a2e\u5275\u65b0\u7684-sars-cov-2-\u6e2c\u8a66\uff0c\u7528\u65bc-fujirebio-\u7684-angebot-schneller-\u548c-hochqua\/","og_site_name":"CENTOGENE","article_published_time":"2020-11-09T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005:":"admincg","\u9810\u4f30\u95b1\u8b80\u6642\u9593":"7 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE baut Portfolio an innovativen SARS-CoV-2-Testl\u00f6sungen aus: Angebot schneller und hochqualitativer COVID-19-Antigen-Tests auf Basis der Technologie von Fujirebio","datePublished":"2020-11-09T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\/"},"wordCount":1406,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"zh-TW","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\/","url":"https:\/\/www.centogene.com\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\/","name":"CENTOGENE baut \u5275\u65b0 SARS-CoV-2-Testl\u00f6sungen \u7522\u54c1\u7d44\u5408\uff1aAngebot schneller \u548c Hochqualitativer COVID-19-Antigen-Tests auf Basis der Technologie von Fujirebio |\u4e16\u7d00\u57fa\u56e0","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2020-11-09T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\/#breadcrumb"},"inLanguage":"zh-TW","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-baut-portfolio-an-innovativen-sars-cov-2-testloesungen-aus-angebot-schneller-und-hochqualitativer-covid-19-antigen-tests-auf-basis-der-technologie-von-fujirebio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE baut Portfolio an innovativen SARS-CoV-2-Testl\u00f6sungen aus: Angebot schneller und hochqualitativer COVID-19-Antigen-Tests auf Basis der Technologie von Fujirebio"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"\u4e2d\u5fc3\u57fa\u56e0","description":"\u5f15\u9818\u7cbe\u6e96\u91ab\u7642","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-TW"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"\u4e2d\u5fc3\u57fa\u56e0","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"\u7ba1\u7406\u54e1","url":"https:\/\/www.centogene.com\/tw\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/posts\/2303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/comments?post=2303"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/posts\/2303\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/media?parent=2303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/categories?post=2303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/tags?post=2303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}